1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Sejbal, J.
Kotovych, G.
Cann, J.R.
Stewart, J.M.
Gera, L.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C6 H15 N4 O2 1
175.209
D-ARGININE
D-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C5 H9 N O3
131.130
n
4-HYDROXYPROLINE
HYDROXYPROLINE
L-peptide linking
C11 H13 N O2
191.226
n
ALPHA-AMINO-2-INDANACETIC ACID
L-peptide linking
C9 H15 N O2
169.221
OCTAHYDROINDOLE-2-CARBOXYLIC ACID
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C7 H9 N O2 S
171.217
n
BETA(2-THIENYL)ALANINE
L-peptide linking
US
J.Med.Chem.
JMCMAR
0151
0022-2623
39
1281
1292
10.1021/jm950485f
8632435
An NMR, CD, molecular dynamics, and fluorometric study of the conformation of the bradykinin antagonist B-9340 in water and in aqueous micellar solutions.
1996
US
J.Am.Chem.Soc.
JACSAT
0004
0002-7863
116
7532
Combined Approach of NMR and Molecular Dynamics within a Biphasic Membrane Mimetics: Conformation and Orientation of the Bradykinin Antagonist Hoe 140
1994
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1321.574
bradykinin antagonist B-9340
1
syn
polymer
no
yes
(DAR)RP(HYP)G(TIH)S(IGL)(OIC)R
RRPPGASGXR
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
repository
Initial release
Version format compliance
Atomic model
Database references
Derived calculations
Non-polymer description
Structure summary
Version format compliance
1
0
1995-12-07
1
1
2008-03-24
1
2
2011-07-13
Y
1995-07-28
REL
1
MOLECULAR SIMULATIONS,INC
refinement
BIOGRAF
DAR
1
n
1
DAR
1
A
ARG
2
n
2
ARG
2
A
PRO
3
n
3
PRO
3
A
HYP
4
n
4
HYP
4
A
GLY
5
n
5
GLY
5
A
TIH
6
n
6
TIH
6
A
SER
7
n
7
SER
7
A
IGL
8
n
8
IGL
8
A
OIC
9
n
9
OIC
9
A
ARG
10
n
10
ARG
10
A
author_defined_assembly
1
monomeric
A
HYP
4
4-HYDROXYPROLINE
A
HYP
4
PRO
A
TIH
6
BETA(2-THIENYL)ALANINE
A
TIH
6
ALA
A
IGL
8
ALPHA-AMINO-2-INDANACETIC ACID
A
IGL
8
GLY
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
A
GLY
TIH
5
6
149.02
1
7.88
0.50
120.30
128.18
A
A
A
NE
CZ
NH1
DAR
DAR
DAR
1
1
1
N
1
-6.92
0.50
120.30
113.38
A
A
A
NE
CZ
NH2
DAR
DAR
DAR
1
1
1
N
1
4.43
0.50
120.30
124.73
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
2
2
2
N
1
-6.00
0.50
120.30
114.30
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
2
2
2
N
1
4.63
0.50
120.30
124.93
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
10
10
10
N
1
-3.14
0.50
120.30
117.16
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
10
10
10
N
1
A
PRO
3
-32.35
104.86
1
A
TIH
6
173.60
119.46
1
A
IGL
8
81.17
-157.12
1
A
OIC
9
-93.07
59.25
B9340
AN NMR, CD, MOLECULAR DYNAMICS, AND FLUOROMETRIC STUDY OF THE CONFORMATION OF THE BRADYKININ ANTAGONIST B-9340 IN WATER AND IN AQUEOUS MICELLAR SOLUTIONS
1
Y
N
covale
1.372
A
PRO
3
A
C
PRO
3
1_555
A
HYP
4
A
N
HYP
4
1_555
covale
1.344
A
HYP
4
A
C
HYP
4
1_555
A
GLY
5
A
N
GLY
5
1_555
covale
1.353
A
GLY
5
A
C
GLY
5
1_555
A
TIH
6
A
N
TIH
6
1_555
covale
1.355
A
TIH
6
A
C
TIH
6
1_555
A
SER
7
A
N
SER
7
1_555
covale
1.350
A
SER
7
A
C
SER
7
1_555
A
IGL
8
A
N
IGL
8
1_555
covale
1.377
A
IGL
8
A
C
IGL
8
1_555
A
OIC
9
A
N
OIC
9
1_555
covale
1.358
A
OIC
9
A
C
OIC
9
1_555
A
ARG
10
A
N
ARG
10
1_555
covale
1.358
A
DAR
1
A
C
DAR
1
1_555
A
ARG
2
A
N
ARG
2
1_555
ANTAGONIST
BRADYKININ ANTAGONIST, ANTAGONIST
1BDK
PDB
1
1BDK
RRPPGASGXR
1
10
1BDK
1
10
1BDK
A
1
1
10
BINDING SITE FOR RESIDUE DAR A 1
Software
2
BINDING SITE FOR RESIDUE OIC A 9
Software
3
A
ARG
2
A
ARG
2
2
1_555
A
PRO
3
A
PRO
3
2
1_555
A
TIH
6
A
TIH
6
3
1_555
A
SER
7
A
SER
7
3
1_555
A
IGL
8
A
IGL
8
3
1_555
1
P 1